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Self-immolative chemistry is based on the cascade of disassembling reactions triggered by the adequate sti-
mulation and leading to the sequential release of the smaller constituent elements. This review will focus on the
possibilities that this type of chemistry oﬀers to nanomedicine research, which is an area where the stimuli
responsive behavior is always targeted. There are some examples on the use of self-immolative chemistry for
prodrugs or nanoparticles for drug delivery, but there is still an exciting land of opportunities waiting to be
explored. This review aims at revising what has been done so far, but, most importantly, it aims at inspiring new
research of self-immolative chemistry on nanomedicine.
1. Introduction
Nanomedicines, which have been deﬁned as those therapeutic or
imaging agents in the nanometer scale that control the biodistribution
and enhance the eﬃcacy of a therapeutic agent, have experienced a
growing interest lately. Undoubtedly, cancer has been the disease in
which nanomedicine has focused most of its eﬀorts because of its un-
ique attractive features for drug delivery, diagnosis and imaging [1].
However, the translation from the laboratory to the clinic remains
challenging since few nanomedicines have been approved for clinical
use by the FDA [2,3].
One of the main drawbacks of current treatments is the lack of se-
lectivity of the drugs, since those molecules are not usually capable of
accumulating selectively only in the damaged areas. As a consequence,
it is usual the induction of side eﬀects in patients, such as cancer me-
tastasis. In order to avoid that, the eﬀort of nanotechnologists has been
headed towards the development of alternative treatments in which,
ideally, drugs would only aﬀect concrete areas, thus lessening drug
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doses and side eﬀects alike. Those systems are commonly known as
drug delivery systems.
Most of the research carried out on nanomedicines for cancer
treatment are based on therapeutic nanoparticle (NP) platforms. In this
sense, NPs for drug delivery provide many advantages compared to the
traditional forms of drugs, such as: control over the pharmacokinetic
proﬁle reducing the potential toxicity of a drug, protection of the
therapeutic agent against potential biodegradation, the possibility of
designing combined therapies loading various drugs within the same
platform, and the possibility of developing targeted nanoparticles to
speciﬁc tissues [4,5] or cells [6], which might be relevant when deli-
vering cytotoxic drugs or to penetrate certain biological barriers.
Although targeted drug delivery nanosystems oﬀer the possibility to
enhance the bioavailability of drugs at the disease site, additional and
interesting features can be included into nanomedicines in order to
incorporate on-demand responsive behavior. In this sense, stimuli-re-
sponsive nanocarriers are able to control drug release by reacting to
naturally occurring stimuli characteristic of the treated pathology, or
external stimuli that can be remotely applied by the clinician (Fig. 1).
The scientiﬁc literature on responsive nanocarriers is full of examples of
both external stimuli, such as temperature [7], magnetic ﬁeld [8], light
[9] and ultrasound [10]; and internal stimuli, such as pH [11], enzymes
[12] or redox species [13].
The challenge when designing stimuli-responsive nanomedicines
relies on the moiety employed to confer that responsiveness. An inter-
esting approach consist of the so-called self-immolative systems, which
are macromolecules programmed trough their synthesis to undergo
head-to-tail disassembly into the building blocks in response to certain
events in a domino-like fashion (Fig. 2).
In this sense, Shabat’s group laid the foundations of this new
chemistry in 2003, when they reported for the ﬁrst time smart self-
immolative dendrimers which showed self-degradation upon stimula-
tion [14]. Later on, they reported an interesting design based on a linear
polyurethane with a protecting group on the terminal amine that acted
as the trigger. Once the protecting group was removed, sequential 1,6-
elimination and decarboxylation reactions led to the original monomer
precursors [15].
In general, Self-Immolative Polymers (SIPs) are produced through a
polymerization reaction of the appropriate monomer to then cap the
terminal head-group of the polymer with a speciﬁc protecting group,
leading to a polymer with a trigger. Then, the selective cleavage of the
protecting group would initiate the polymer sequential fragmentation
into the original building blocks from head to tail. Therefore, the ap-
propriate selection of the trigger would allow the design of many dif-
ferent responsive materials.
This review will ﬁrst introduce some general concepts of self-im-
molative chemistry, including the main properties of self-immolative
spacers. Then, the application of self-immolative chemistry to nano-
medicine will be revised, including some examples of prodrugs, par-
ticle-like polymeric vehicles and mesoporous silica nanoparticles
capped with self-degradable gatekeepers.
2. Self-immolative spacers
The simplest self-immolative moiety is composed of a protecting
group linked to a spacer, which is also linked to a reporter, which is
ﬁnally released (Fig. 3).
The use of self-immolative spacers allows the release of a single
molecule upon application of a certain stimulus. That stimulus breaks
the bond between the protecting group (or equivalently, the trigger).
Fig. 1. Schematic representation of stimuli-responsive nanoparticles for drug delivery. Nanoparticle (yellow); Drug (red); Gatekeeper (e.g. polymer) (black); Tumor cells (grey). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Trigger
Fig. 2. Schematic representation of the cleavage of a trigger on a self-immolative polymer
leading to the head to tail disassembly into its building blocks.
SPACERPG
Reporter: Drug, dye, Polymer chain
PG Protecting group
Fig. 3. General structure of a self-immolative spacer: A protecting group connected to a
spacer which is linked to a reporter.
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After that, an electronic cascade starts leading to an intermediate spe-
cies. Finally, the bond between the spacer and cargo cleaves and the
reporter is released (Fig. 4).
From the chemical point of view, the self-immolation process is
normally driven by a cooperative rise in the entropy along with the
formation of thermodynamically stable products. Generally speaking,
self-immolative spacers can be classiﬁed in two main groups, depending
on the particular disassembling process: (1) 1,4-,1,6-, or 1,8-
Elimination; or (2) Cyclisation [16]. Additionally, it is possible to
combine both types of spacers to tune the degradation rates in self-
immolative polymers [17].
2.1. 1,4-,1,6-, or 1,8-Elimination
These spacers are based on aromatic species that present electron
donor groups in orto or meta positions and good leaving groups in
benzylic positions. The electron donor group, usually amino, hydroxyl
or thiol, normally leads to 1,4- or 1,6-Eliminations. Thus, once the self-
immolation process starts trough the cleavage of the protecting group,
the electron donor group transmit the electron pair to the aromatic ring,
starting an electronic cascade that leads to the disassembly of the spacer
(Fig. 5).
Interestingly, 1,8-Elimination does not lead to the release of the
leaving group in molecules such as naphthalene. Moreover, 1,10-
Elimination or successive do not provide the cargo. This behavior has
not been completely elucidated although some explanations have been
given, such as the excessive energy barrier that is necessary to break
aromaticity and the repulsion of the ortho-hydrogens that prevents the
formation of the planar structure necessary for good electron delocali-
zation [16].
2.2. Cyclisation
Spacers suﬀering cyclisation are based on lineal alkyl chains or
aromatic molecules with substituents in ortho. Once the trigger would
be cleaved, a nucleophilic attack on a carbonyl group or an electrophilic
aliphatic carbon leads to the cyclisation of the spacer, which provokes
the release of the reporter [16]. Both examples are shown in Fig. 6.
A complete and exhaustive description of self-immolative spacers
can be found elsewhere [16,18–21].
The election of the protecting group emerges as a powerful tool to
control the on-demand beginning of the self-immolation. A number of
protecting groups useful in a clinical scenario have been reported.
Those stimuli can be classiﬁed in three main groups: (1) chemical
(hydrogen peroxide or pH); (2) enzymatic; and (3) luminescent (ul-
traviolet or near-infrared light). Table 1 summarizes the diﬀerent types
of stimuli-responsive protecting groups.
3. Self-immolative chemistry in nanomedicine
3.1. Prodrugs based on self-immolative spacers
The term prodrug refers to masked forms of active drugs. These
compounds are supposed to be inactive or to have negligible ther-
apeutic activity. In order to recover it, prodrugs must be converted into
the active drug. That process usually takes place either through a
chemical or enzymatic process. These structures are usually designed to
increase the selectivity of the treatment so that doses can be reduced
[53]. In this sense, it is possible to design prodrugs-like precursors with
self-immolative properties capable of releasing dye molecules. Thus, it
would be possible to monitor the self-immolation thanks to the pre-
sence of dye molecules being released.
For an enzymatic reaction to happen it is necessary the formation of
temporary bonds between the substrate and the active site of the en-
zyme. Then, if an enzyme is to bind a substrate, the later should show
adequate accessibility for the active site. In that sense, it has been
shown that the addition of a self-immolative spacer between the trigger
and the deliverable drug increases the accessibility of the enzyme to the
speciﬁc substrate. Then, the introduction of self-immolative fragments
leads to higher rates of bioconversion and, then, higher therapeutic
activity [54]. Therefore, the prodrug will travel throughout the body
without therapeutical activity until arriving at the desired area, where
it will suﬀer self-immolation and it will recover its therapeutical ac-
tivity.
There are several examples of enzymes that have been utilized in the
design of this kind of molecules. Cathepsin B is an cysteine protease
which is involved in many pathologies and oncogenic processes in
humans [55]. For instance, it is overexpressed in the lysosomes of many
cancer cells. The self-immolative spacer p-aminobenzyl alcohol has
been widely used in combination with various combinations of dipep-
tides to provide sensitivity to this enzyme. For instance, the dipeptides
Phe-Lys and Lys-Lys have been used in the design of selective prodrug-
inspired probes capable of releasing a ﬂuorogenic peptide [56]. Besides,
the Phe-Lys combination has shown great eﬃcacy both in vitro and in
vivo, showing much less toxicity in healthy areas than its active coun-
terpart [57]. In order to monitor endogenous alkaline phosphatase in
living cells, p-hydroxybenzyl alcohol has been used as spacer between a
phosphate moiety (enzyme substrate) and the dye resoruﬁn [35]. DT-
diaphorase, an enzyme that is overexpressed in some malignant tumor,
has also been used as enzymatic trigger through self-immolative linkers.
In particular, the use of a quinone propionic acid-based moiety allows
to incorporate two camptothecin drug molecules at a time on each
prodrug [44]. Furthermore, there is an enzyme (human carboxyl-es-
terase-2) that has proved its eﬃcacy in the cleavage of a self-im-
molative ester to provide the active form of the potent anticancer drug
platinum-acridine [43].
With regard to self-immolative prodrugs undergoing chemical ac-
tivation, the majority of the examples reported involves a conversion
mechanism based on the action of the tripeptide glutathione (GSH),
although designs sensitive to hydrogen peroxide have also been re-
ported [22]. GSH, which is known to be overexpressed in certain types
of tumors [58,59], is capable of reducing disulﬁde bonds, as those
1) Trigger Cleavage
2) Reporter Release
SPACERPG
Stimulus
SPACERPG SPACERPG
Fig. 4. Disassembling procedure: The protecting group (PG) is cleaved upon stimulus
application (1), which ﬁnally lead to reporter release (2).
X XH
X XH
a)
b)
Protecting group
Leaving group
Fig. 5. Spacers and elimination procedures. a) 1,4-Elimination; b) 1,6-Elimination. When
the protecting group is cleaved, an active nucleophile is generated, which donate the
electron pair and initiates the self-immolation.
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present in disulﬁde-based self-immolative linkers [60]. Besides, con-
jugation of self-immolative prodrugs with gold nanoparticles has also
been described, leading to a system with dual drug capability and tar-
geting ability [37]. In order to verify the eﬀective drug cleavage due to
the action of GSH, a dendritic system bearing one molecule of camp-
tothecin and one of inactive dye was reported. Then, when GSH cleaves
the trigger, both drug and dye are released in their active form, thereby
obtaining a light signal only if the drug has indeed been released [42].
So far, the examples shown usually involve two drug molecules
maximum, however, it might be interesting the use of polymer chains
bearing pendant cleavable disulﬁde-based prodrugs, so more drug
molecules could be delivered. In particular, this approximation has
been found to be successful in treating HIV, since it is possible to carry
multiple drugs at a time thus leading to a more eﬀective combination
therapy [36,61]. Following a similar approximation, a polyethylene
glycol block bearing a small amount of prodrugs (doxorubicin) on its
side chain has been reported. In this case, the addition of tetrazine leads
to almost complete conversion into the free drug thanks to the con-
version of a phenyl vinyl ether into a phenol [33].
3.2. Nanocarriers based on self-immolative moieties
As it has been shown above, it is very frequent the use of single self-
immolative units in order to design prodrug-like molecules. Besides, it
is also possible to design several types of nanovehicles by using self-
immolative fragments in combination with other macromolecular
structures. In particular, we will provide here an overview on polymer
capsules, vesicles, micelles and nucleic acid-nanoparticles as well.
Moreover, we will take a look to the unexplored domain of using self-
immolative chemistry to hamper undesired drug release from meso-
porous silica nanoparticles.
3.2.1. Polymer capsules
In the last few years a number of techniques to synthesize particles
or capsules made of self-immolative elements have been developed
[62]. In that sense, the synthesis of pH responsive microcapsules
composed of self-immolative polymers was published in 2010 for the
ﬁrst time [31]. When subjected to certain stimuli, the presence of the
triggering units led to the disruption of the carrier and the release of the
cargo. In a diﬀerent design, self-immolative polymers were formulated
as nanoparticles sensitive to both ultraviolet and near-infrared light
[50]. Furthermore, more examples comprising other designs of self-
immolative polymers sensitive to various wavelengths have also been
reported [49,51,52]. The introduction of aryl boronic esters within the
polymer chain has led to multiple designs of hydrogen peroxide re-
sponsive polymer nanoparticles [26,27,63]. Moreover, dual stimuli-
responsive polymer nanoparticles have also been published, including
pH and light [29,64] or hydrogen peroxide and pH [25]. Finally, heat-
responsive polymer nanoparticles have been recently reported. Upon
heating, the carrier undergoes a retro-Diels Alder reaction that leads to
a furfural carbamate that suﬀers elimination, thus provoking the de-
gradation of the carrier [65].
3.2.2. Polymeric micelles and vesicles
It is also possible to design vehicles that self-assemble spontaneously
from linear structures to three dimensional polymeric carriers.
Polymeric micelles (Fig. 7, top) are core-shell structures formed by
amphiphilic block copolymers in aqueous solution, with the hydro-
phobic block forming the core and the hydrophilic the shell. Depending
on the polymer composition and the preparation, those copolymers can
form vesicular assemblies, the so-called polymersomes. Polymersomes
(Fig. 7, bottom) are similar to liposomes, since they show a bilayer
structure with an aqueous inner cavity capable of hosting hydrophilic
drugs [66]. In particular, for a ﬁxed hydrophilic part, the increase of the
size of the hydrophobic section leads ﬁrst to micelles and then, worms,
vesicles and tubular vesicles respectively [67].
The disassembly of this kind of nanocarriers usually involves
changes in the solubility of the hydrophobic block, which demand a
cooperative behavior of all monomer units. For that reason, it is par-
ticularly interesting the use of self-immolative components in order to
obtain that cooperative behavior during disassembly. These self-de-
structive fragments allow the complete disintegration of the vehicles
only in the desired area, thereby releasing selectively the cargo.
Various approximations have been proposed in order to construct
self-immolative polymeric micelles. The general design normally com-
prises two polyethylene glycol blocks having a self-immolative con-
struction within them. Polyethylene glycol is interesting since not only
provides a hydrophilic segment to the block copolymer, but also pro-
vides the carrier with improved stealth properties. It is usual the use of
a self-immolative block containing multiple triggering points along the
chain. In that sense, hydrogen peroxide-responsive poly(amino ester)s
[48] as well as disulﬁde containing polycarbonates [47] have been used
as building blocks for the hydrophobic component. Nonetheless, in
order to reduce the triggering events, and therefore, increase the eﬃ-
cacy of the self-immolative process, it would be desirable to have only
one triggering unit. To achieve that, micelles formed from amphiphilic
polymers containing a poly(ethyl glyoxylate) undergoing head-to-tail
depolymerization have been also synthesized [24].
The inclusion of pendant self-immolative groups [46] or linear self-
immolative polycarbamates [41] within hydrophilic segments has led
to light-responsive polymersomes. In that sense, self-immolative poly-
mersomes can be decorated with targeting peptides to improve the
therapeutic eﬃcacy of the carrier [23]. Moreover, enzyme-responsive
self-immolative polymeric vesicles capable of addressing antimicrobial
resistance have shown their eﬃcacy in vitro [34].
3.2.3. Nucleic acid-based nanoparticles
It has been observed that there are particular three-dimensional
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Fig. 6. Spacers suﬀering cyclisation. a) Attack to carbonyl;
b) Attack to aliphatic carbon.
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Table 1
Stimuli-responsive protecting groups for self-immolative spacers.
Protecting Group Trigger References
Chemical Stimulus
OR
B
O
O
H2O2 [22–27]
N
H
O
OR
Acid pH [28–31]
HO R
Basic pH [32]
O
H
N
O
R
O Tetrazine [33]
Enzymatic Stimulus
HN
O
R
Penicillin G-Amidase [34]
HO
P
HO
OR
O Alkaline Phosphatase [35]
S S RR' Glutathione [22,36–41]
O2N
NO2
S
O
O
OR
Glutathione [42]
N NH
N
R'
R
Human carboylesterase-2 [43]
O
O
N
N
O
OR
DT-Diaphorase [44]
Light Stimulus
NO2
OR
R
Ultraviolet [24,41,45–51]
HO
Br
O
O
O N
N OR
O
Near-Infrared [50–52]
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arrangements of nucleic acids with exquisite properties that their linear
or circular counterparts do not show. For instance, those structures
show better binding with complementary strands, stability against en-
zyme degradation and internalization. Although it is common the
coating of solid gold nanoparticles with DNA strands, it is also possible
to design vehicles entirely made of nucleic acids. In that sense, DNA
micelles bearing light [45] and reductive [40] self-immolative moieties
have been reported. Moreover, it is also possible the combination of
miRNA with polymeric prodrugs [39] or polymer chains bearing pen-
dant prodrugs [38] to give rise to particle-like polyplexes. The main
advantage of all these designs is that it is possible to transport drugs, in
their active or inactive form, that, once the stimulus is applied, are
released in combination with diﬀerent nucleic acids, which also show
therapeutic eﬃcacy and biocompatibility.
3.3. Self-immolative moieties as gatekeepers for mesoporous silica
nanoparticles
Among all the nanoparticles that are being investigated as potential
nanomedicines, mesoporous silica nanoparticles (MSNs) have drawn
the attention of the scientiﬁc community because of their attractive
properties to be used as drug delivery nanosystems [68–72]. Basically,
they are very robust, because of their silica network constitution; they
provide a high loading capacity, thanks to the network of cavities that
can be loaded with many diﬀerent therapeutic agents; and they are very
easy to chemically modify, thanks to the silanol groups present on their
surface.
The synthesis of MSNs is based on the sol-gel process, through the
hydrolysis and condensation of the silica precursors, which will then
form a network of silica [73]. The mesoporous structure of those na-
noparticles is achieved thanks to the use of surfactants as structure
directing agents during the synthetic process. Then, once the process is
ﬁnished, removing the surfactant would lead to the network of cavities
typical from these materials. Finally, to obtain nanoparticle, the syn-
thetic process needs to be carried out under very dilute conditions,
following a modiﬁcation of the sol-gel process. Following this protocol,
spherical nanoparticles with diameters between 100 and 200 nm and
empty pores of ca. 2 nm can be obtained (Fig. 8).
When using MSNs as drug delivery vectors, there is an important
aspect that needs to be considered: they are materials with open por-
osity, which means that it is very easy to introduce drugs into their
pores, but it is also very easy for those drugs to diﬀuse out.
Consequently, the pore entrances should be closed to avoid the pre-
mature release of the cargo, but those gates need to be designed so they
can be opened on command to release the cargo. This is precisely the
way that stimuli-responsive nanocarriers work: they release their con-
tent on-command in response to certain stimuli, which can be internal
and characteristic of the treated pathology or external and remotely
applied by the clinician.
The scientiﬁc literature is full of examples of MSNs able to respond
to diﬀerent stimuli, and among them, systems take advantage of the
signiﬁcant variations in pH (gastrointestinal track, tumor micro-
environment or endosomal/lysosomal compartments of the cell) are
very attractive [11]. In this sense, cancer cells normally use aerobic
glycolysis as their source of energy, which leads to lactate accumulation
Micelles
Polymersomes
Hydrophilic
Hydrophobic
Fig. 7. Cross-section of the Self-Assembly of amphiphilic block copolymers. Top:
Formation of micelles; Bottom: Formation of polymersomes.
Fig. 8. Scanning Electron Microscopy (left) and
Transmission Electron Microscopy (right) images of
Mesoporous Silica nanoparticles.
Fig. 9. Schematic representation of a pH sensitive nanocarrier composed of Mesoporous
Silica Nanoparticles and Self-Immolative Polymers.
Fig. 10. Fluorescent dye cumulative release at physiological pH and acid pH.
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within the tumor microenvironment that lowers the pH. Thus, em-
ploying functional moieties able to respond to pH variations as gate-
keepers on MSNs seems an interesting approach to speciﬁcally release
therapeutic agents on those sites. Up to date, the combination of MSNs
with self-immolative molecules sensitive to pH variations has been
explored from 2 perspectives: in response to acid pH [28] or to basic pH
[32].
Acid pH responsive nanocarriers have been prepared through the
combination of MSNs and self-immolative polymers in a unique carrier
that is able to combine the beneﬁts of both components: the robustness
and great loading capacity of MSNs and the responsive behavior of SIPs.
At physiological pH the SIP would maintain its structure while at acid
pH it would start to disassemble, thus opening the pores and allowing
the release of the cargo (Fig. 9).
The self-immolative polymer was based on a polyurethane back-
bone with a tert-butyloxycarbonyl protecting group acting as the
trigger. The polymer was produced using a previously synthesized
monomer from 4-aminobenzylalcohol and phenyl chloroformate, and
polymerized using a tin catalyst. The trigger sensitive to acid pH was
based on a tert-butyl carbamate. Once the polymer was characterized
and the self-immolative behavior was observed, it was grafted to the
surface of MSNs in two stages. First, the nanoparticles were functio-
nalised with a linker through silanol chemistry to then anchor the
polymer to the other end of the linker. The successful grafting of SIP on
MSNs was characterized through several techniques and the cargo re-
lease under diﬀerent pHs was evaluated using a ﬂuorescent dye as a
model molecule (Fig. 10).
At physiological pH there was a very small amount of dye released,
probably due to the dye molecules entrapped into the polymer network.
However, when the pH of the solution was acid, a great release of the
cargo was observed, conﬁrming the disassembling of the polymer and
allowing the dye molecules to diﬀuse out of the pores.
On the other hand, the responsive system to basic pH was produced
through the capping of MSNs with self-immolative molecular gates
[32]. That molecular gate was a carbamate derivative that could un-
dergo a 1,6-elimination reaction through a quinone-methide cascade
under basic conditions. The self-immolative molecule was anchored to
the surface of MSNs through silanol chemistry after the cargo molecules
(sulforhodamine B) were introduced into the network of cavities of the
nanocarriers. The cargo release from the designed carriers was eval-
uated at diﬀerent pHs, observing that at acid and neutral pHs it was
highly inhibited. However, at pH 8 the release reached almost 100%
after 120min, which was indicative that the self-immolative process
took place, inducing the rupture of the gate and promoting the cargo
release.
3.4. Biocompatibility and cytotoxicity
It has been shown that they by-products of the self-immolation
could interact with enzymes (that trigger the self-immolation) [74].
However, there is still a lack of research regarding the study of the
biocompatibility and cytotoxicity of the by-products of the self-im-
molation. In general, the studies shown here do not focus on the eﬀect
of those residues. These nanocarriers have been shown to be bio-
compatible when the stimulus is not applied, thus showing cytotoxicity
only upon stimulation. Since the stimuli should take place only in the
tumor cells, the side eﬀects that might be caused by the by-products
would only have sort of a synergistic eﬀect with the cytotoxic drug.
4. Conclusions
The most important concepts of Self-Immolative Chemistry have
been here presented, highlighting the importance of the trigger to in-
itiate the disassembling process and the spacer for allowing the cascade
reactions. This type of materials developed by Shabat’s group oﬀer very
attractive features to be used on nanomedicine research, especially in
stimuli-responsive systems. This review has presented some re-
presentative examples but we honestly consider that there are many
diﬀerent possibilities and unexplored opportunities for this type of self-
immolative chemistry in the area of Nanomedicine.
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